Eric Lefkofsky Advances Cancer Treatment

Eric Lefkofsky Advances Cancer Treatment

Cancer has now become a more pronounced disease as it was before. According to statistics, people living with cancer make 40% of the population in the US. The number of people living with cancer is expected to increase as years go by. Cancer treatment has, therefore, become crucial to all health facilities aiming at offering treatment at all levels. Tempus has advanced cancer treatment by improving data collection and technology used in hospitals. Tempus is led by Erick Lefkofsky who is the co-founder of this company.

Eric Lefkofsky’s idea of collecting more detailed and reliable data about cancer patients struck his mind after his wife was diagnosed with breast cancer. It is at this point that Erick realized a big gap that existed between data collection and technology. He realized that a lot of data are collected about cancer patients but the information collected is not channeled in a streamlined way to make use of it during cancer treatments. Despite that technology was embraced in hospitals, this technology had not been incorporated in data collection and research analysis.

Tempus came in as a result of those gaps that were discovered by Lefkofsky aiming at transforming how cancer care was delivered to patients. Tempus has created a platform that effectively analyzes patients’ molecular as well as clinical data that has made cancer treatments more accurate and efficient. This company also developed soft wares for analytical work but obtaining clinical and medical data for analysis was initially a problem.

The company also faced another problem whereby the information or rather data collected about cancer patients was stored as progress notes. The data was inform of free text field that made it difficult to capture the information and analyze it efficiently. Fortunately, Tempus has developed soft wares such as optical character recognition capabilities and natural language processing that collects pertinent notes that are quickly transformed into structured data that help advance cancer treatment and care.

Cancer treatment has been advanced by Tempus whereby molecular and cellular data has now been involved in their analytical work. According to Tempus, human genes hold clues of what is happens to the body cells and therefore genome sequencing can make it easier and more efficient in fighting cancer disease. Tempus has made it easy for doctors to pair a specific type of cancer with the appropriate treatment hence improving the prognosis of cancer treatments.

Erick Lefkofsky is the co-founder and the CEO of Tempus. He was born in 1969 and studied at the University of Michigan where he acquired his degree in law in the year 1993.Even though he attained high qualifications in law, Erick was swept in the Dot.com revolution where he emerged as an influential player in the Tempus Company. He spends most of his time in Chicago as this is where Tempus is located.

Eric is also a professor at the University of Chicago Booth School of business teaching a course on Entrepreneurship. He has also written a business book about how technology affects business. The work of Tempus has brought advanced cancer treatment globally hence improving the lives of cancer patients.